Frommer D J
Med J Aust. 1975 Nov 22;2(21):793-6. doi: 10.5694/j.1326-5377.1975.tb106311.x.
A double-blind trial of zinc sulphate given by mouth (220 mg, three times a day) and placebo was undertaken in patients with benign gastric ulcers. The drug was given for a three-week period and the healing of the ulcers was estimated from results of barium-meal X-ray films taken immediately before and after this period. There were ten patients taking zinc sulphate and eight patients taking placebo. The two groups of patients were comparable in all respects, including initial ulcer size. Patients taking zinc sulphate had an ulcer healing rate three times that of patients treated with placebo. This difference was significant (P less than 0-05). Complete healing of ulcers occurred more frequently in the patients taking zinc sulphate than in patients treated with placebo. The placebo group contained more patients whose ulcers did not heal at all, than the group taking zinc sulphate. No side effects from zinc sulphate were noted. There was no evidence of zinc deficiency in any of the patients.
对患有良性胃溃疡的患者进行了一项口服硫酸锌(220毫克,每日三次)与安慰剂的双盲试验。药物服用为期三周,根据在此期间前后立即拍摄的钡餐X光片结果评估溃疡的愈合情况。有10名患者服用硫酸锌,8名患者服用安慰剂。两组患者在所有方面均具有可比性,包括初始溃疡大小。服用硫酸锌的患者溃疡愈合率是服用安慰剂患者的三倍。这种差异具有显著性(P小于0.05)。服用硫酸锌的患者溃疡完全愈合的情况比服用安慰剂的患者更频繁。安慰剂组中溃疡完全未愈合的患者比服用硫酸锌组更多。未观察到硫酸锌的副作用。在任何患者中均无锌缺乏的证据。